Cost Minimization of Using Activated Prothrombin Complex Concentrate Versus Recombinant Activated Factor Vii in Patients With a Nd B Hemophilia in Presence of Inhibitors

Value in Health - United Kingdom
doi 10.1016/j.jval.2016.09.500

Related search